Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Theravex Bioactive Solutions (Tissue Care Plus and Oral) are novel bioactive saline formulations containing calcium chloride and magnesium dichloride hexahydrate. Developed by the Universidad Complutense de Madrid, these solutions are designed to enhance soft tissue healing and root coverage in patients undergoing periodontal surgery, specifically the Modified Free Gingival Graft (M-FGG) technique for treating RT1-RT2 gingival recessions. Theravex Tissue Care Plus is applied intraoperatively to soak the harvested graft and treat the recipient site, while Theravex Oral is utilized as a postoperative rinse to support tissue gain, improve color integration, and mitigate postoperative pain. The bioactive nature of the solution aims to optimize the biological environment for graft integration and cellular regeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Theravex Bioactive Solutions (Tissue Care Plus + Oral).